Weight-Loss Drugs, GLP-1 Medications To Only Be Sold With Prescription From Registered Practitioner: CDSCO

The Central Drugs Standard Control Organization (CDSCO) has mandated that weight-loss drugs, specifically GLP-1 medications, will only be available through prescriptions from registered healthcare practitioners. This decision aims to regulate the growing market for these medications, which have gained popularity for their effectiveness in weight management. The CDSCO also emphasized that any form of advertising, whether direct or indirect, promoting these drugs to the public could lead to regulatory actions under the Drugs Rules. This move reflects the Indian government’s commitment to ensuring the safe and responsible use of pharmaceutical products, particularly those that can significantly impact health and well-being. With increasing concerns over the misuse and potential side effects of weight-loss medications, this regulation is expected to encourage patients to seek professional medical advice before considering such treatments. The CDSCO's action is a response to the rising trend of self-medication and the need for stringent oversight in the pharmaceutical sector.